Congratulations to Dr Lynn Butler, who has been appointed as an NCMM Young Associate Investigator (YAI).
Dr Butler’s appointment as an NCMM YAI comes as part of her recruitment to the Arctic University of Norway (UiT)’s KG Jebsen Thrombosis Research and Expertise Center (TREC). She is currently an Assistant Professor at the Department of Molecular Medicine and Surgery at the Karolinska Institute in Sweden, and will officially start her role at UiT in September.
Dr Butler’s main research interest is the role of endothelial cells in thrombotic disease development. Throughout her scientific career, Dr. Butler has studied basic and clinical vascular biology, with particular focus on endothelium and its role in pathophysiological processes, such as chronic inflammation, herpes virus infection, and atrial and venous thrombosis.
KG Jebsen TREC working to improve patient outcomes and reduce the burden of venous thrombosis (VTE) on society
The vision of KG Jebsen TREC is to diminish patients’ suffering and the burden of venous thrombosis (VTE) on society. By identifying novel biomarkers and extending the understanding of the pathogenesis of the disease, TREC aims to improve risk stratification to offer targeted prevention and treatment to high risk subjects.
VTE, a collective term for deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common disease affecting between 7-10,000 individuals in Norway, and relates to 2-3000 deaths annually. In addition, 20-50% of DVT patients develop post-thrombotic syndrome (PTS) caused by impaired venous circulation. PTS is characterised by pain and swelling of the affected extremity with hampered mobility, reduced quality of life, and increased risk of disability pension.
About the NCMM Associate and Young Associate Investigator Network
Altogether, the NCMM AI and YAI network now consists of 33 outstanding investigators; a list of current AI and YAIs can be viewed here.
The AI and YAI category is designed for outstanding senior or younger scientists who are currently based in Norway, and applicants' expertise must be compatible with the research areas of NCMM. Furthermore, Associate Investigators must be interested in contributing to the building of an NCMM Molecular Medicine and Translational Research Network.
Associate Investigators and Young Associate Investigators continue working at their host institutions, and are credited with an affiliation to NCMM. Nominations are made for three years and will be renewable.